PubRank

Toshikazu Saito

Author PubWeight™ 54.77‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Schizophrenia: from the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers. World J Biol Psychiatry 2009 1.64
2 Neurons show distinctive DNA methylation profile and higher interindividual variations compared with non-neurons. Genome Res 2011 1.61
3 Transient lymphocytic panhypophysitis associated with SIADH leading to diabetes insipidus after glucocorticoid replacement. Intern Med 2003 1.54
4 Phase I study of YM155, a novel survivin suppressant, in patients with advanced solid tumors. Clin Cancer Res 2009 1.51
5 Thrombopoietin-producing hepatocellular carcinoma. Intern Med 2003 1.42
6 Detection of chromosomal structural alterations in single cells by SNP arrays: a systematic survey of amplification bias and optimized workflow. PLoS One 2007 1.25
7 Pulmonary artery obstruction caused by thoracic aortic dissection: a case with unique pathological findings. Circ J 2004 1.05
8 Comorbid childhood gender identity disorder in a boy with Asperger syndrome. Psychiatry Clin Neurosci 2008 1.00
9 Decreased expression of NEFH and PCP4/PEP19 in the prefrontal cortex of alcoholics. Neurosci Res 2004 0.99
10 Homocysteic acid induces intraneuronal accumulation of neurotoxic Abeta42: implications for the pathogenesis of Alzheimer's disease. J Neurosci Res 2005 0.96
11 Advanced glycation end products (AGE) and their receptor (RAGE) in the brain of patients with Creutzfeldt-Jakob disease with prion plaques. Neurosci Lett 2002 0.96
12 The practice of child and adolescent psychiatry: a survey of early-career psychiatrists in Japan. Child Adolesc Psychiatry Ment Health 2009 0.95
13 Probucol markedly reduces HDL phospholipids and elevated prebeta1-HDL without delayed conversion into alpha-migrating HDL: putative role of angiopoietin-like protein 3 in probucol-induced HDL remodeling. Atherosclerosis 2008 0.93
14 Glyceraldehyde-derived advanced glycation end products in Alzheimer's disease. Acta Neuropathol 2004 0.91
15 Evaluation of whole genome amplification methods using postmortem brain samples. J Neurosci Methods 2007 0.91
16 [Prevalence of intestinal canine and feline parasites in Saitama Prefecture, Japan]. Kansenshogaku Zasshi 2009 0.88
17 Apolipoprotein E4 frequencies in a Japanese population with Alzheimer's disease and dementia with Lewy bodies. PLoS One 2011 0.87
18 [Reduction in alcohol consumption: therapeutic goal in alcohol dependence treatment]. Nihon Arukoru Yakubutsu Igakkai Zasshi 2013 0.86
19 Biological studies on alcohol-induced neuronal damage. Psychiatry Investig 2008 0.85
20 The effect of ethanol on cell fate determination of neural stem cells. Alcohol Clin Exp Res 2005 0.85
21 Neuroprotective effects of Yi-Gan San against beta amyloid-induced cytotoxicity on rat cortical neurons. Prog Neuropsychopharmacol Biol Psychiatry 2008 0.85
22 Effect of antidepressants on brain-derived neurotrophic factor (BDNF) release from platelets in the rats. Prog Neuropsychopharmacol Biol Psychiatry 2010 0.85
23 Low serum BDNF and food intake regulation: a possible new explanation of the pathophysiology of eating disorders. Prog Neuropsychopharmacol Biol Psychiatry 2008 0.84
24 Ethanol inhibition of neural stem cell differentiation is reduced by neurotrophic factors. Alcohol Clin Exp Res 2004 0.83
25 Decreased cardiac MIBG uptake, its correlation with clinical symptoms in dementia with Lewy bodies. Psychiatry Res 2009 0.83
26 S(G), S(I), and EGP of exercise-trained middle-aged men estimated by a two-compartment labeled minimal model. Am J Physiol Endocrinol Metab 2002 0.81
27 Persistent phenotypic correction of central diabetes insipidus using adeno-associated virus vector expressing arginine-vasopressin in Brattleboro rats. Mol Ther 2003 0.81
28 Evaluation of annexin A5 as a biomarker for Alzheimer's disease and dementia with lewy bodies. Front Aging Neurosci 2013 0.81
29 Neuronal cell-type specific DNA methylation patterns of the Cacna1c gene. Int J Dev Neurosci 2012 0.81
30 Lithium-induced suppression of transcription repressor NRSF/REST: effects on the dysfunction of neuronal differentiation by ethanol. Eur J Pharmacol 2008 0.81
31 Imaging improves diagnosis of dementia with lewy bodies. Psychiatry Investig 2009 0.81
32 Differences in E2F subunit expression in quiescent and proliferating vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 2002 0.81
33 Interleukin-12p40 gene (IL-12B) polymorphism and Type 1 diabetes mellitus in Japanese: possible role in subjects without having high-risk HLA haplotypes. Diabetes Res Clin Pract 2005 0.81
34 Ethanol-induced augmentation of annexin IV expression in rat C6 glioma and human A549 adenocarcinoma cells. Alcohol Clin Exp Res 2002 0.80
35 Comparison of the usefulness of brain perfusion SPECT and MIBG myocardial scintigraphy for the diagnosis of dementia with Lewy bodies. Dement Geriatr Cogn Disord 2008 0.80
36 Attitudes of early-career psychiatrists in Japan toward child and adolescent psychiatry and their career decision. Psychiatry Clin Neurosci 2010 0.80
37 Neuroserpin is expressed in early stage of neurogenesis in adult rat hippocampus. Neuroreport 2010 0.80
38 [Gender dysphoria in pervasive developmental disorders]. Seishin Shinkeigaku Zasshi 2011 0.79
39 The study of cognitive characteristics in Asperger's disorder by using a modified Prisoner's Dilemma game with a variable payoff matrix. PLoS One 2012 0.79
40 Cytotoxicity of acetaldehyde-derived advanced glycation end-products (AA-AGE) in alcoholic-induced neuronal degeneration. Alcohol Clin Exp Res 2005 0.79
41 Influence of comorbid alcohol use disorder on treatment response of depressive patients. J Neural Transm (Vienna) 2014 0.79
42 [Trends in therapy for alcoholism]. Seishin Shinkeigaku Zasshi 2007 0.78
43 Investigation of annexin A5 as a biomarker for Alzheimer's disease using neuronal cell culture and mouse model. J Neurosci Res 2010 0.78
44 Neurotoxicity of acetaldehyde-derived advanced glycation end products for cultured cortical neurons. J Neuropathol Exp Neurol 2003 0.78
45 Consensus paper of the WFSBP task force on biological markers: biological markers for alcoholism. World J Biol Psychiatry 2013 0.78
46 Hyperglycemia enhances VSMC proliferation with NF-kappaB activation by angiotensin II and E2F-1 augmentation by growth factors. Mol Cell Endocrinol 2002 0.78
47 Differences in the preferred antipsychotics for acute schizophrenia among young psychiatrists in two regions of Japan. Asian J Psychiatr 2010 0.78
48 WISC-III profiles of subjects with high-functioning pervasive developmental disorders who visited child and adolescent psychiatry clinics at a university hospital. Psychiatry Clin Neurosci 2009 0.78
49 Two-layer appearance on brain perfusion SPECT in idiopathic normal pressure hydrocephalus: a qualitative analysis by using easy Z-score imaging system, eZIS. Dement Geriatr Cogn Disord 2009 0.77
50 Augmentation of ethanol-induced cell damage and activation of nuclear factor-kappa B by annexin IV in cultured cells. Alcohol Clin Exp Res 2003 0.77
51 Hikikomori as a possible clinical term in psychiatry: a questionnaire survey. BMC Psychiatry 2012 0.77
52 [Epigenetic regulation in alcohol-related brain damage]. Nihon Arukoru Yakubutsu Igakkai Zasshi 2008 0.77
53 The role of neural stem cells for in vitro models of schizophrenia: neuroprotection via Akt/ERK signal regulation. Schizophr Res 2010 0.77
54 [Difference between alcohol dependence and nicotine dependence in cognitive dysfunction]. Nihon Arukoru Yakubutsu Igakkai Zasshi 2003 0.77
55 Ethanol-induced augmentation of annexin IV in cultured cells and the enhancement of cytotoxicity by overexpression of annexin IV by ethanol. Biochim Biophys Acta 2002 0.76
56 The common aspects of pathophysiolgy of alcoholism and depression. Nihon Arukoru Yakubutsu Igakkai Zasshi 2009 0.76
57 Effects of atelocollagen on neural stem cell function and its migrating capacity into brain in psychiatric disease model. J Neural Transm (Vienna) 2013 0.76
58 Pervasive developmental disorders and autism spectrum disorders: are these disorders one and the same? Psychiatry Investig 2010 0.76
59 Stem cell therapy: a new approach to the treatment of refractory depression. J Neural Transm (Vienna) 2014 0.76
60 Beat-to-beat evaluation of systolic time intervals during bicycle exercise using impedance cardiography. Tohoku J Exp Med 2004 0.75
61 [Promising therapy of neural stem cell transplantation for FASD model--neural network reconstruction and behavior recovery]. Nihon Arukoru Yakubutsu Igakkai Zasshi 2011 0.75
62 Plasticity-related gene 1 is important for survival of neurons derived from rat neural stem cells. J Neurosci Res 2013 0.75
63 [History of research on diabetes insipidus]. Nihon Naika Gakkai Zasshi 2002 0.75
64 [The contributions of Dr. Ishii to the international scientific society of ISBRA]. Nihon Arukoru Yakubutsu Igakkai Zasshi 2011 0.75
65 [Difference of visual attention between smokers and never-smokers]. Nihon Arukoru Yakubutsu Igakkai Zasshi 2003 0.75
66 [Mental and behavioral disturbances caused by psychotropic agents: with special reference to alcohol dependence]. Seishin Shinkeigaku Zasshi 2008 0.75
67 [Alcohol dependent sleep disorder]. Ryoikibetsu Shokogun Shirizu 2003 0.75
68 [Recommendation for revision of the General Principles of Suicide Prevention Policy]. Seishin Shinkeigaku Zasshi 2012 0.75
69 [Substance related disorders and addictive disorders]. Seishin Shinkeigaku Zasshi 2014 0.75
70 [Acquired immunodeficiency syndrome associated with Burkitt's leukemia diagnosed by ileus]. Nihon Naika Gakkai Zasshi 2008 0.75
71 [Study on mental diseases: neural stem cells]. Seishin Shinkeigaku Zasshi 2005 0.75
72 [Neural network abnormalities caused by alcohol: approach for repair using neural stem cells]. Nihon Shinkei Seishin Yakurigaku Zasshi 2008 0.75
73 [Alcohol dependence and mood disorders]. Seishin Shinkeigaku Zasshi 2010 0.75
74 [Concept of disorders of psychotropic drugs]. Seishin Shinkeigaku Zasshi 2010 0.75
75 [Possible alterations in brain neural network by ethanol]. Nihon Arukoru Yakubutsu Igakkai Zasshi 2004 0.75
76 [Family therapy and its perspective]. Ryoikibetsu Shokogun Shirizu 2003 0.75
77 Successful olanzapine treatment of anorexia nervosa in a girl with pervasive developmental disorder not otherwise specified. Psychiatry Clin Neurosci 2008 0.75
78 [A survey of alcoholics and their families on controlled drinking as a treatment goal: discussions on new treatment approaches]. Nihon Arukoru Yakubutsu Igakkai Zasshi 2013 0.75
79 Risperidone-induced Pisa syndrome. J Clin Psychiatry 2002 0.75
80 [Possible approach of regenerative medicine to treat alcohol-induced brain damage]. Nihon Arukoru Yakubutsu Igakkai Zasshi 2009 0.75
81 [Hypertension secondary to primary aldosteronism]. Nihon Rinsho 2004 0.75
82 [The analysis of impairment and repair of neural network by ethanol: in vitro and in vivo studies using neurons and neural stem cells]. Nihon Arukoru Yakubutsu Igakkai Zasshi 2008 0.75
83 [Alcohol-related disorders]. Seishin Shinkeigaku Zasshi 2006 0.75
84 Effects of typical (haloperidol) and atypical (risperidone) antipsychotic agents on protein expression in rat neural stem cells. Neurochem Int 2009 0.75
85 [Status and treatment of alcohol dependence associated with mental disorders]. Seishin Shinkeigaku Zasshi 2010 0.75
86 [Pisa syndrome]. Ryoikibetsu Shokogun Shirizu 2003 0.75
87 [Differences in cognitive function in patients with tobacco dependence and alcoholism]. Nihon Shinkei Seishin Yakurigaku Zasshi 2002 0.75
88 [Primary cardiac lymphoma: a case report]. J Cardiol 2002 0.75
89 [The Basic Act on Measures against Alcohol-related Health Harm and Role of General Psychiatrists--With focus on SBRIT and Deadly Triangle]. Seishin Shinkeigaku Zasshi 2015 0.75
90 [Diagnosis of and therapy for patients with alcoholism]. Seishin Shinkeigaku Zasshi 2004 0.75
91 Pisa syndrome-like peculiar posture occurred while running was successfully improved with risperidone. Psychiatry Clin Neurosci 2006 0.75
92 [Discussion meeting on past steps and challenges today of the social insurance union of societies related to internal medicine]. Nihon Naika Gakkai Zasshi 2014 0.75
93 [Internationalization in studies of psychiatry]. Seishin Shinkeigaku Zasshi 2011 0.75
94 Rhotekin modulates differentiation of cultured neural stem cells to neurons. J Neurosci Res 2012 0.75
95 [Primary aldosteronism due to unilateral adrenal hyperplasia]. Nihon Rinsho 2006 0.75
96 [Technical evaluation of medical practice--conversion from things to skill and art. Topics: IV. Challenge to technical evaluation on medical practice; 2. Doctor fee in the National Health Insurance of Japan for services of physician to inpatients of internal medicine]. Nihon Naika Gakkai Zasshi 2014 0.75
97 [Shoshin beriberi after 20-year use of an alternative medicine]. Nihon Naika Gakkai Zasshi 2006 0.75
98 [Revision of the National Health Insurance System and the practice of internal medicine]. Nihon Naika Gakkai Zasshi 2002 0.75
99 [Einfacher Rausch]. Ryoikibetsu Shokogun Shirizu 2003 0.75
100 [Alcohol hallucinosis]. Ryoikibetsu Shokogun Shirizu 2003 0.75